Logo-jrcm
J Res Clin Med. 2024;12: 28.
doi: 10.34172/jrcm.33349
  Abstract View: 72
  PDF Download: 69

Original Article

Multimorbidity raises the odds of decease in COVID-19 patients: An Iranian prospective study

Masood Faghih Dinevari 1 ORCID logo, Mohammad Hossein Somi 1, Leila Mokhtari 2, Elham Sadeghi Majd 3, Zeinab Nikniaz 1* ORCID logo

1 Liver and Gastrointestinal Diseases Research Center, Tabriz University of medical sciences, Tabriz, Iran
2 Imam Reza Hospital, Tabriz University of Medical Sciences, Tabriz, Iran
3 Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran
*Corresponding Author: Zeinab Nikniaz, Email: znikniaz@hotmail.com

Abstract

Introduction: The prevalence of noncommunicable diseases is high in Iran. We postulated that multimorbidity may affect the rate of mortality from COVID-19. So, we investigated the relationship between multimorbidity and COVID-19 mortality.

Methods: We used medical reports for collecting clinical laboratory data of patients with COVID-19 in this prospective investigation. Moreover, we documented whether the patient had a known diagnosis of different comorbidities. The patients with more than one comorbidity were considered multimorbidity. The length of follow-up was till participants were discharged from the hospital or deceased. The main outcome was to evaluate the relationship between multimorbidity and death in COVID-19 hospitalized patients.

Results: The present prospective study included 1842 patients with COVID-19 with a multimorbidity rate of 37.40%. About 24.6% of participants with more than four comorbidities died. However, this value was about 17% in participants with less than four comorbidities. The odds of mortality from COVID-19 were 53% greater in patients with diabetes. Also, the odds of death were 2.05 (1.21, 3.45) times greater in patients with comorbidities≥4.

Conclusion: The results indicated a high rate of multimorbidity in patients with COVID-19 which is related to a higher death rate. So, in countries with higher multimorbidity rates such as Iran, it is necessary to design efficient approaches to alleviate the spread of COVID-19.

First Name
 
Last Name
 
Email Address
 
Comments
 
Security code


Abstract View: 73

Your browser does not support the canvas element.


PDF Download: 69

Your browser does not support the canvas element.

Submitted: 27 Mar 2023
Accepted: 04 Mar 2024
ePublished: 16 Oct 2024
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)